Pulmocide

Series-B+
pulmocide.com Biotech & Healthcare London, United Kingdom Founded 2013 11-50
Total Funding $174.4M
Latest Round $52M Series-B+
Last Announced Dec 6, 2022
Investors 13 Backers
Decision Makers 6 Verified

About Pulmocide

Pulmocide is developing novel inhaled medicines for serious respiratory diseases

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters London, United Kingdom
Year Founded 2013
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website pulmocide.com
Domain Registered Date Nov 13, 2012

Social & Network Presence

X / Twitter Profile @PulmocideLtd (33 followers) Created on Apr 2018
LinkedIn Corporate Not linked

Company Milestones & Timeline

6 Events
  1. Capital Raise

    Raised $52,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $92,000,000 · Series-B+

  3. Milestone

    X account created (@PulmocideLtd)

    33 followers

  4. Capital Raise

    Raised $30,400,000 · Series-B+

  5. Milestone

    Company founded

    London, United Kingdom

  6. Milestone

    Website domain registered

    pulmocide.com

Investors & Backers

13
Adjuvant Capital
Asahi Kasei Pharma
Cystic Fibrosis Foundation
F-Prime Capital
IP Group
Jeito Capital
Johnson & Johnson Innovation
Longwood Fund
Pictet Alternative Advisors
SR One
SV Health Investors
Touchstone Innovations
Vivo Capital

Funding History

3 Rounds
Series-B+ · Dec 6, 2022
Series-B+ · May 27, 2021
$92,000,000 Source
Series-B+ · Mar 20, 2017
$30,400,000 Source

Founders & Leadership

7

Ashish Sagrolikar

Chief Commercial Officer

Work email & phone locked Unlock →

Dan Burgess

Chairman and Chief Executive Officer

Work email & phone locked Unlock →

Garth Rapeport

Cofounder

Work email & phone locked Unlock →

Jennifer Cayer

Chief Business Officer

Work email & phone locked Unlock →

John Murray

Cofounder

Work email & phone locked Unlock →

Kazuhiro Ito

Cofounder

Work email & phone locked Unlock →

Pete Strong

Chief Scientific Officer and Cofounder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts